Back

SGLT2 inhibitors in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

9 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: TAVI and aortic stenosis: imaging, prediction, outcomes Intervention HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Luigi Spadafora

Sapienza University of Rome, Latina (Italy)

6 More presentations in this session

Presentation thumbnail
Association between CT-derived extracellular volume and echocardiographic parameters in severe aortic stenosis
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides
Presentation thumbnail
What drives mortality in paradoxical low-flow, low-gradient aortic stenosis?
Doctor M. Moura (Porto, PT)
Abstract Slides
Presentation thumbnail
Acceleration time as a predictor of true severity in low-flow low-gradient aortic stenosis: insights from dobutamine stress echocardiography
Doctor F. Rodrigues Santos (Viseu, PT)
Abstract Slides
Presentation thumbnail
Transcatheter versus surgical aortic valve replacement in bicuspid aortic stenosis: baseline characteristics and early clinical outcomes
Doctor C. Santos Jorge (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Valve sizing in TAVR: avoiding over- and under-sizing
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
TAVI and aortic stenosis: imaging, prediction, outcomes

The Event

Event poster

Heart Failure 2026

9 May 2026 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources